Keyphrases
Cancer Patients
100%
Dendritic Cells
100%
Cell Preparation
100%
Cell Cytokines
100%
Monocyte-derived Dendritic Cells (MoDCs)
100%
Alpha Type
100%
Cytokine Cocktail
100%
Cell Generation
37%
Tumor Necrosis Factor-α
25%
Interleukin-1β
25%
IL-12p70
25%
CCR7
25%
Maturation Cocktails
25%
Monocyte-derived DC
25%
Interleukin-6
12%
Prostaglandin E2
12%
Interferon-γ
12%
Interferon-α (IFN-α)
12%
T Cells
12%
Adaptation
12%
Cell-based
12%
Stimulatory Capacity
12%
Antigen-specific
12%
Tumor-draining Lymph Nodes
12%
In Vivo Efficacy
12%
Dendritic Cell Maturation
12%
Cancer Vaccine
12%
Serum-free Medium
12%
Interleukin-23 (IL-23)
12%
Vaccine Research
12%
Costimulatory Molecules
12%
Clinical Grade
12%
Inhibitory Molecules
12%
Programmed Death-ligand 1 (PD-L1)
12%
Vaccine Trial
12%
CD83
12%
ILT2
12%
Maturation Markers
12%
Polyinosinic-polycytidylic Acid
12%
Mixed Lymphocyte Reaction
12%
Cell Parameters
12%
ILT3
12%
Influenza Antigen
12%
Neuroscience
Tumor Necrosis Factor Alpha
100%
Interleukin 1beta
100%
In Vivo
50%
In Vitro
50%
Prostaglandin E
50%
T Cell
50%
Interferon Gamma
50%
Lymph Node
50%
Lymphocyte
50%
Cell Maturation
50%
Interferon Alfa
50%
Cancer Vaccine
50%
Polyinosinic:polycytidylic Acid
50%
Immunology and Microbiology
Cytokine
100%
Monocyte
100%
Dendritic Cell
100%
Maturation
100%
Tumor Necrosis Factor Alpha
18%
Upregulation
18%
Interleukin-1
9%
Interleukin 1beta
9%
Interleukin-6
9%
Lymph Node
9%
T Cell
9%
Secretion (Process)
9%
Vaccination Policy
9%
Prostaglandin E
9%
Interferon Gamma
9%
Antigen Specificity
9%
Interferon Alfa
9%
Cell Maturation
9%
Influenza
9%
Cancer Vaccine
9%
Co-Stimulatory Molecule
9%
Programmed Death-Ligand 1
9%
Polyinosinic:polycytidylic Acid
9%
CD83
9%
Mixed Lymphocyte Reaction
9%